New study demonstrates efficacy of all-oral treatment regimens in adolescents with hepatitis C virus

Saturday, April 16, 2016 - 16:00 in Health & Medicine

Adolescents with Hepatitis C (HCV) could benefit from a combination of direct-acting antivirals, according to new data. The study demonstrated that adolescent patients with HCV genotype 1 aged 12 to 18 years who were treated for 12 weeks with a fixed dose combination of ledipasvir and sofosbuvir attained high sustained virologic response (SVR) rates.

Read the whole article on Science Daily

More from Science Daily

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net